Overexpression of NELFE contributes to gastric cancer progression via Wnt/β-catenin signaling-mediated activation of CSNK2B expression

BackgroundAccumulating evidence has highlighted the importance of negative elongation factor complex member E (NELFE) in tumorigenesis. However, the relationship between NELFE and gastric cancer (GC) remains unclear. This study aimed to explore the expression pattern and specific function of NELFE in GC.MethodsNELFE expression was evaluated by immunohistochemistry and qRT-PCR in GC tissues, respectively. Cell proliferation, migration and invasion were measured by CCK-8, colony formation, transwell assays, and nude mice model. Bioinformatics analysis was performed to search potential target genes of NELFE, and a Cignal Finder 10-Pathway Reporter Array was used to explore potential signaling pathways regulated by NELFE. Dual-luciferase reporter assays, qRT-PCR and western blotting were conducted to verify their regulatory relationship. The expression correlations among NELFE, beta -catenin and CSNK2B were further explored by immunohistochemistry on consecutive resections.ResultsNELFE was significantly overexpressed in GC tissues both in protein and mRNA level and negatively correlated with the prognosis of GC patients. Gain- and loss-of-function experiments showed that NELFE potentiated GC cell proliferation and metastasis in vitro and in vivo. CSNK2B was identified as a downstream effector of NELFE. Wnt/beta -catenin signaling may mediate the regulation of CSNK2B by NELFE. In addition, NELFE, beta -catenin and CSNK2B were all remarkably upregulated in tumor tissues compared with adjacent normal tissues, and their expression levels in GC were positively correlated with each other.ConclusionOur findings reveal a new NELFE-Wnt/beta -catenin-CSNK2B axis to promote GC progression and provide new candidate targets against this disease.

Automated summary

In gastric cancer, overexpression of NELFE is negatively correlated with the prognosis of patients, and NELFE promotes proliferation and metastasis of GC cells both in vitro and in vivo. CSNK2B is identified as a downstream effector of NELFE, and Wnt/beta-catenin signaling may mediate the regulation of CSNK2B by NELFE. Additionally, NELFE, beta-catenin, and CSNK2B are all significantly upregulated in tumor tissues and their expression levels in GC are positively correlated with each other.